Literature DB >> 8163999

Clinical correlates of postmortem brain changes in schizophrenia: decreased brain weight and length correlate with indices of early impairment.

E C Johnstone1, C J Bruton, T J Crow, C D Frith, D G Owens.   

Abstract

From a postmortem study of the brains of 56 patients with schizophrenia and 56 controls, 38 cases whose clinical state had been objectively documented in life were examined to determine whether relations existed between features of the illness and postmortem findings. Decreased brain weight was significantly related (p < 0.05) to poor premorbid global function and to poor academic record, and decreased brain length was related to poorer premorbid global function (p < 0.05) and more severe negative symptoms. These relations are consistent with the view that morphological changes in the brain occur early in the course of the disease--that is, they are in some sense "developmental." An excess of "focal damage" in the patient group relative to controls was unrelated to the presence of morphological change or to features of illness, but was more common in female schizophrenic patients and was also correlated with evidence of cerebrovascular disease. This may possibly be due to a discrepancy between the groups in mode and cause of death.

Entities:  

Mesh:

Year:  1994        PMID: 8163999      PMCID: PMC1072879          DOI: 10.1136/jnnp.57.4.474

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  25 in total

1.  Computerized transverse axial scanning (tomography). 1. Description of system.

Authors:  G N Hounsfield
Journal:  Br J Radiol       Date:  1973-12       Impact factor: 3.039

2.  Three forms of the clinical tests of the sensorium and their reliability.

Authors:  E Withers; J Hinton
Journal:  Br J Psychiatry       Date:  1971-07       Impact factor: 9.319

3.  A standardized psychiatric assessment scale for rating chronic psychotic patients.

Authors:  M Krawiecka; D Goldberg; M Vaughan
Journal:  Acta Psychiatr Scand       Date:  1977-04       Impact factor: 6.392

4.  Diagnostic criteria for use in psychiatric research.

Authors:  J P Feighner; E Robins; S B Guze; R A Woodruff; G Winokur; R Munoz
Journal:  Arch Gen Psychiatry       Date:  1972-01

5.  Widespread cerebral gray matter volume deficits in schizophrenia.

Authors:  R B Zipursky; K O Lim; E V Sullivan; B W Brown; A Pfefferbaum
Journal:  Arch Gen Psychiatry       Date:  1992-03

6.  Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics.

Authors:  D G Owens; E C Johnstone; C D Frith
Journal:  Arch Gen Psychiatry       Date:  1982-04

7.  The disabilities of chronic schizophrenia--their nature and the factors contributing to their development.

Authors:  D G Cunningham Owens; E C Johnstone
Journal:  Br J Psychiatry       Date:  1980-04       Impact factor: 9.319

8.  Cerebral ventricular size and cognitive impairment in chronic schizophrenia.

Authors:  E C Johnstone; T J Crow; C D Frith; J Husband; L Kreel
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

9.  Neuropathology of schizophrenia.

Authors:  J R Stevens
Journal:  Arch Gen Psychiatry       Date:  1982-10

10.  Anterior pituitary hormone secretion in chronic schizophrenics.

Authors:  I N Ferrier; E C Johnstone; T J Crow; I Rincon-Rodriguez
Journal:  Arch Gen Psychiatry       Date:  1983-07
View more
  3 in total

Review 1.  Consensus on minimal criteria of clinical and neuropathological diagnosis of schizophrenia and affective disorders for post mortem research. Report from the European Dementia and Schizophrenia Network (BIOMED I).

Authors:  P Riederer; W Gsell; L Calza; E Franzek; G Jungkunz; K Jellinger; G P Reynolds; T Crow; F F Cruz-Sánchez; H Beckmann
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 2.  Neurobiological background of negative symptoms.

Authors:  Silvana Galderisi; Eleonora Merlotti; Armida Mucci
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

3.  Morphological alterations of the pyramidal and stellate cells of the visual cortex in schizophrenia.

Authors:  Ioannis Mavroudis; Foivos Petrides; Dimitrios Kazis; Symela Chatzikonstantinou; Eleni Karantali; Alin Ciobica; Alin-Constantin Iordache; Romeo Dobrin; Constantin Trus; Samuel Njau; Vasiliki Costa; Stavros Baloyannis
Journal:  Exp Ther Med       Date:  2021-04-22       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.